US 8268618
Repressing endogenous CCR5 gene expression in cells using engineered zinc finger proteins
granted A61KA61K48/00A61K48/005
Quick answer
US patent 8268618 (Repressing endogenous CCR5 gene expression in cells using engineered zinc finger proteins) held by Sangamo Biosciences, Inc. expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Biosciences, Inc.
- Grant date
- Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61K, A61K48/00, A61K48/005, A61P, A61P11/00